Healthtech Late Stage Investors & VC Firms
494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.
Shenasa
TehranLate Stage
Broad Vision Funds
BeijingSeed–Late Stage
7 people
Samara Asset Group
BirkirkaraPre-Seed–Late Stage
6 people
Soleus Capital
GreenwichLate Stage
2 people
INP Capital
VancouverSeed–Late Stage
6 people
Alium Capital
SydneySeed–Late Stage
5 people
Anchor Capital
BostonSeed–Late Stage
11 people
Formation Group
Los AltosPre-Seed–Late Stage
8 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
Blue Heron Capital
RichmondSeed–Late Stage
7 people
Brace Pharma
AtlantaLate Stage
3 people
Muirwoods Ventures
SeoulSeed–Late Stage
AXIS Participaciones Empresariales
MadridSeed–Late Stage$810K – $43.2M
4 people
Sagitta Family Office
CopenhagenGrowth–Late Stage
5 people
For Good Ventures
Late Stage
Xerys
ParisSeed–Late Stage$16M – $97M
1 person
YF Capital
ShanghaiSeries A–Late Stage
4 people
EDB Investments
SingaporeSeed–Late Stage
11 people
NGN Capital
New YorkSeries A–Late Stage
5 people
Horizon Technology Finance
FarmingtonGrowth–Late Stage
2 people
Sangel Capital
ShenzhenSeed–Late Stage
2 people
Daybreak Partners
Pre-Seed–Late Stage
1 person
Urania Ventures
BerlinSeed–Late Stage
Bracket Capital
Los AngelesSeed–Late Stage
4 people
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Late Stage Investors & VC Firms (1725)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)Healthtech Growth Investors & VC Firms (1269)Healthtech Investors & VC Firms in Global (1181)
Data sourced from public filings and firms' own websites — see our methodology.








































